These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1023 related articles for article (PubMed ID: 12630911)
1. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP). Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911 [TBL] [Abstract][Full Text] [Related]
2. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase. Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829 [TBL] [Abstract][Full Text] [Related]
3. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor. Fernandez-Catalan C; Bode W; Huber R; Turk D; Calvete JJ; Lichte A; Tschesche H; Maskos K EMBO J; 1998 Sep; 17(17):5238-48. PubMed ID: 9724659 [TBL] [Abstract][Full Text] [Related]
4. Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion. Itoh Y; Takamura A; Ito N; Maru Y; Sato H; Suenaga N; Aoki T; Seiki M EMBO J; 2001 Sep; 20(17):4782-93. PubMed ID: 11532942 [TBL] [Abstract][Full Text] [Related]
5. Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2. Imai K; Ohuchi E; Aoki T; Nomura H; Fujii Y; Sato H; Seiki M; Okada Y Cancer Res; 1996 Jun; 56(12):2707-10. PubMed ID: 8665498 [TBL] [Abstract][Full Text] [Related]
6. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system. Jo Y; Yeon J; Kim HJ; Lee ST Biochem J; 2000 Feb; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509 [TBL] [Abstract][Full Text] [Related]
7. Progesterone differentially regulates the membrane-type matrix metalloproteinase-1 (MT1 -MMP) compartment of proMMP-2 activation in MG-63 cells. Luo XH; Liao EY Horm Metab Res; 2001 Jul; 33(7):383-8. PubMed ID: 11507673 [TBL] [Abstract][Full Text] [Related]
8. Differential roles of TIMP-4 and TIMP-2 in pro-MMP-2 activation by MT1-MMP. Hernandez-Barrantes S; Shimura Y; Soloway PD; Sang QA; Fridman R Biochem Biophys Res Commun; 2001 Feb; 281(1):126-30. PubMed ID: 11178970 [TBL] [Abstract][Full Text] [Related]
9. Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanism. Monea S; Lehti K; Keski-Oja J; Mignatti P J Cell Physiol; 2002 Aug; 192(2):160-70. PubMed ID: 12115722 [TBL] [Abstract][Full Text] [Related]
10. Direct activation of pro-matrix metalloproteinase-2 by leukolysin/membrane-type 6 matrix metalloproteinase/matrix metalloproteinase 25 at the asn(109)-Tyr bond. Nie J; Pei D Cancer Res; 2003 Oct; 63(20):6758-62. PubMed ID: 14583471 [TBL] [Abstract][Full Text] [Related]
11. Fluorescence quenching studies of matrix metalloproteinases (MMPs): evidence for structural rearrangement of the proMMP-2/TIMP-2 complex upon mercurial activation. Stack MS; Itoh Y; Young TN; Nagase H Arch Biochem Biophys; 1996 Sep; 333(1):163-9. PubMed ID: 8806767 [TBL] [Abstract][Full Text] [Related]
12. Enhancement of membrane-type 1-matrix metalloproteinase (MT1-MMP) production and sequential activation of progelatinase A on human squamous carcinoma cells co-cultured with human dermal fibroblasts. Sato T; Iwai M; Sakai T; Sato H; Seiki M; Mori Y; Ito A Br J Cancer; 1999 Jun; 80(8):1137-43. PubMed ID: 10376963 [TBL] [Abstract][Full Text] [Related]
13. Cell surface activation of progelatinase A (proMMP-2) and cell migration. Nagase H Cell Res; 1998 Sep; 8(3):179-86. PubMed ID: 9791731 [TBL] [Abstract][Full Text] [Related]
14. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression. Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545 [TBL] [Abstract][Full Text] [Related]
15. Activation of pro-MMP-2 mediated by MT1-MMP in human salivary gland carcinomas: possible regulation of pro-MMP-2 activation by TIMP-2. Kayano K; Shimada T; Shinomiya T; Nakai S; Hisa Y; Aoki T; Seiki M; Okada Y J Pathol; 2004 Apr; 202(4):403-11. PubMed ID: 15095267 [TBL] [Abstract][Full Text] [Related]
16. Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic human keratinocytes. Baumann P; Zigrino P; Mauch C; Breitkreutz D; Nischt R Br J Cancer; 2000 Nov; 83(10):1387-93. PubMed ID: 11044366 [TBL] [Abstract][Full Text] [Related]
17. Cloning, expression, and characterization of chicken tissue inhibitor of metalloproteinase-2 (TIMP-2) in normal and transformed chicken embryo fibroblasts. Aimes RT; Li LH; Weaver B; Hawkes S; Hahn-Dantona EA; Quigley JP J Cell Physiol; 1998 Mar; 174(3):342-52. PubMed ID: 9462696 [TBL] [Abstract][Full Text] [Related]
18. Tissue inhibitor of metalloproteinase-2 (TIMP-2) expression during cardiac neural crest cell migration and its role in proMMP-2 activation. Cantemir V; Cai DH; Reedy MV; Brauer PR Dev Dyn; 2004 Dec; 231(4):709-19. PubMed ID: 15497141 [TBL] [Abstract][Full Text] [Related]
19. Activation of matrix metalloproteinase-2 (MMP-2) by membrane type 1 matrix metalloproteinase through an artificial receptor for proMMP-2 generates active MMP-2. Nishida Y; Miyamori H; Thompson EW; Takino T; Endo Y; Sato H Cancer Res; 2008 Nov; 68(21):9096-104. PubMed ID: 18974156 [TBL] [Abstract][Full Text] [Related]
20. Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferation. Benyon RC; Hovell CJ; Da Gaça M; Jones EH; Iredale JP; Arthur MJ Hepatology; 1999 Oct; 30(4):977-86. PubMed ID: 10498650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]